Abstract

Four metabolites, teraspiridoles A–D (2–5), formed from the merger of diterpene and modified indole scaffold were obtained from an Aspergillus terreus isolate. The structures and absolute configurations of these natural products were established using NMR, mass spectrometry, Marfey’s method, VCD, and ECD data. Teraspiridole B (3) exhibited weak inhibition of planaria regeneration/survival.
Natural products containing a tricyclic 9,9a-dihydro-1H-imidazo[1,2-a]indol-3(2H)-one scaffold (1) (Figure 1) are quite rare with most examples originating from just a few fungal genera (e.g., Penicillium and Aspergillus).1 In most cases, 1 is linked to substituted quinazolinones as exemplified by the tremorgenic mycotoxins fumiquinazoline A,2 tryptoquivaline,3 and others4 (Figure 1). Scaffold 1 also cryptically appears as part of a tetracyclic subunit in the sponge-derived kapakahines,5 as well as the fungal-derived metabolite chaetominine 6 (Figure 1). The virtual absence of 1 among other groups of natural products is surprising given the modular architecture of secondary-metabolite biosynthetic pathways1 and the frequency with which genes from divergent clusters are swapped/duplicated and integrated into new pathways.7 Incorporating compounds containing under-represented natural-product scaffolds like 1 into natural-product libraries is important for enhancing the likelihood of discovering new bioactive molecules.
Figure 1.
The tricyclic 9,9a-dihydro-1H-imidazo[1,2-a]indol-3(2H)-one scaffold (1) and selected metabolites containing 1; note that none of the reported compounds containing scaffold 1 are linked to a diterpene
While preparing natural products for our pure compound library, we encountered a biosynthetically talented Aspergillus terreus isolate. This specimen was obtained from the sediment of a small creek bed (Cedar Creek) near Buffalo Valley, Oklahoma. After culturing the fungus on Cheerios breakfast cereal, 8 LC-PDA ESIMS revealed several metabolites with molecular weights between 560–580 Da (Supporting Information, Figure S1). Our investigation of each compound’s ESIMS and UV data revealed that these metabolites were not attributable to any substance previously reported from A. terreus. However, virtually all other compounds were readily dereplicated as metabolites common for A. terreus, thus supporting the ITS-based taxonomic assignment of this isolate. Mass-guided purification of the unknown metabolites led to the identification of teraspiridoles A–D (2–5) (Figure 2), which constitute a new class of spiro-linked diterpene-indole alkaloids.
Figure 2.
Teraspiridoles A–D (2–5) isolated from A. terreus
Teraspiridole A (2) 9 was obtained as a pale yellow solid. Its molecular formula was determined to be C33H42N2O6 based on HRESIMS, which indicated 14 degrees of unsaturation. Analysis of the 13C NMR and HSQC data showed that 2 contained 10 quaternary carbons (3 carbonyls), 12 methines, 4 methylenes, and 7 methyls (Table 1). The HMBC spectrum showed correlations from H-1 to C-3/5/10/18, as well as from H-5/20/21 to C-4. Together, these data suggested the presence of an α,β-unsaturated ε-caprolactone subunit similar to that observed in the planar structure of toonayunnanin C.10 Further examination of the HMBC (correlations from H-18 to C-10/9/5; H-19 to C-7/8/14/9; H-17 to C-12/13/14; H-33/7 to C-32) and COSY (correlations between H-1 and H-2, H-5 and H-6, H-6 and H-7, H-9 and H-11, H-11 and H-12, H-14 and H-15) data provided evidence that the α,β-unsaturated ε-caprolactone was part of a tetracyclic diterpene fragment (Fragment A, Figure 3).
Table 1.
13C NMR data (100 MHz) of teraspiridoles A–D (2–5) in CD3OD
| position | 2
|
3
|
4
|
5
|
|---|---|---|---|---|
| δC, mult | δC, mult | δC, mult | δC, mult | |
| 1 | 158.3 CH | 158.2 CH | 38.8 CH2 | 38.8 CH2 |
| 2 | 120.2 CH | 120.2 CH | 31.5 CH2 | 31.5 CH2 |
| 3 | 168.8 C | 168.7 C | 175.9 C | 175.9 C |
| 4 | 85.4 C | 85.4 C | 85.6 C | 85.6 C |
| 5 | 53.7 CH | 53.7 CH | 50.1 CH | 50.1 CH |
| 6 | 27.4 CH2 | 27.3 CH2 | 27.6 CH2 | 27.5 CH2 |
| 7 | 80.0 CH | 80.1 CH | 80.4 CH | 80.4 CH |
| 8 | 40.8 C | 40.7 C | 40.7 C | 40.6 C |
| 9 | 55.9 CH | 55.9 CH | 59.1 CH | 59.0 CH |
| 10 | 42.8 C | 42.8 C | 38.6 C | 38.6 C |
| 11 | 20.9 CH2 | 21.0 CH2 | 19.7 CH2 | 19.9 CH2 |
| 12 | 38.9 CH2 | 39.1 CH2 | 39.1 CH2 | 39.3 CH2 |
| 13 | 82.3 C | 82.4 C | 82.1 C | 82.3 C |
| 14 | 58.7 CH | 58.2 CH | 58.8 CH | 58.3 CH |
| 15 | 32.2 CH2 | 33.0 CH2 | 32.3 CH2 | 33.1 CH2 |
| 16 | 89.0 C | 89.3 C | 88.9 C | 89.2 C |
| 17 | 22.7 CH3 | 23.1 CH3 | 22.6 CH3 | 22.9 CH3 |
| 18 | 13.8 CH3 | 13.8 CH3 | 16.5 CH3 | 16.4 CH3 |
| 19 | 11.4 CH3 | 11.6 CH3 | 11.1 CH3 | 11.2 CH3 |
| 20 | 25.9 CH3 | 25.9 CH3 | 25.8 CH3 | 25.8 CH3 |
| 21 | 31.2 CH3 | 31.1 CH3 | 29.4 CH3 | 29.4 CH3 |
| 22 | 84.9 CH | 86.1 CH | 84.9 CH | 86.1 CH |
| 23 | 59.2 CH | 45.4 C | 59.2 CH | 45.4 C |
| 24 | 173.0 C | 177.0 C | 173.0 C | 177.0 C |
| 25 | 136.2 C | 137.6 C | 136.2 C | 137.6 C |
| 26 | 114.6 CH | 116.0 CH | 114.6 CH | 116.0 CH |
| 27 | 128.8 CH | 128.7 CH | 128.8 CH | 128.7 CH |
| 28 | 125.6 CH | 126.0 CH | 125.5 CH | 125.9 CH |
| 29 | 124.1 CH | 123.7 CH | 123.9 CH | 123.6 CH |
| 30 | 140.3 C | 139.7 C | 140.4 C | 139.8 C |
| 31 | 17.6 CH3 | 11.4 CH2 | 17.6 CH3 | 11.5 CH2 |
| 31a | 16.2 CH2 | 16.1 CH2 | ||
| 32 | 170.8 C | 170.7 C | 170.9 C | 170.8 C |
| 33 | 19.9 CH3 | 20.0 CH3 | 19.9 CH3 | 20.0 CH3 |
Figure 3.

Key COSY and HMBC correlations for partial structures A and B, and ROESY correlations for 2.
The remaining atoms in 2 were arranged similar to those observed in metabolites bearing a methylated 1 [HMBC correlations from H-22/29 to C-16, from H-26 to C-30, from H-22 to C-24 (in CDCl3), from H-23 to C-24, and from H-31 to C-24]. Further evidence for the methyl group was deduced from the splitting pattern of the C-23 methine proton (δ 4.27), which appear as a double quartet (1.1 and 6.8 Hz) in CDCl3 (Supporting Information, Table S1). With fragments A and B deciphered, we noted that these assignments resulted in a single quaternary carbon at δ 89.0 (C-16) that we had incorporated into both partial structures. Since our analysis had already accounted for all the atoms in the proposed molecular formula, we interpreted this to mean that C-16 served as a spiro junction between fragments A and B.
The relative configuration of 2 was determined by ROESY experiment (Figure 3). Correlations between H-20 and H-18, H-18 and H-19, H-19 and H-17 indicated that these four methyl groups were on the same face of the diterpene portion of 2. Similarly, correlations between H-21 and H-5, H-5 and H-9, H-9 and H-7, H-9 and H-14 revealed that these protons were on the opposite face of the molecule. Additional correlations between H-14 and H-29, H-17 and H-22, and H-22 and H-23 were essential for assigning the relative configurations of the C-16, C-22, and C-23 as S*,S*,S*, respectively.
The absolute configuration of 2 was established using a combination of Marfey’s method11 and comparisons of ECD and VCD experimental data with theoretical spectra. Acid hydrolysis followed by workup with L-FDAA provided for the identification of L-Ala in 2, which substantiated an S configuration for C-23 (Supporting Information, Figure S2). In addition, ab initio ECD and VCD calculations were carried out to generate theoretical spectra for comparisons with experimentally derived data. Density functional theory (DFT) calculations performed at the B3LYP/6-31+G** level provided ECD and VCD spectra for the two lowest-energy conformers of 2. The ECD and VCD spectra of the two conformers were averaged using the Boltzmann statistical weighing feature in SpecDis 1.60 (sigma value of 0.3 eV) to obtain the theoretical spectra (Figure 4, A and C). Both of the predicted ECD and VCD spectra matched well with the experimental data enabling us to assign the absolute configuration of 2 as 5R,7S,8R,9R,10R,13S,16S,22S,23S.
Figure 4.
Calculated and experimental ECD data for 2 (A) and 3 (B) and VCD data for 2 (C) and 3 (D)
A molecular formula of C34H42N2O6 was established for teraspiridole B (3) 12 based on HRESIMS. This required one additional degree of unsaturation compared to 2. The 13C NMR and HSQC data provided evidence for two new methylenes (δC 11.4 and 16.2) and one new quaternary carbon (δC 45.4) in 3 verses 2 (Table 1). In addition, we noted that one methyl and one methine present in 2 were absent in compound 3. All the other carbon and proton spins (Tables 1 and 2) remained relatively unchanged. In light of the correlation data from COSY (between H-31 and H-31a) and HMBC (H-31/31a to C-23/24, and from NH to C-23) experiments (Supporting Information, Figure S3), we deduced that the L-Ala methyl group in 2 was replaced by a cyclopropane in 3. ROESY correlations confirmed that 2 and 3 shared the same relative configuration (Supporting Information, Figure S3). Comparisons of the ECD and VCD data of 3 with the calculated spectra (Figure 4, B and D) provided absolute configuration of 3 (5R,7S,8R,9R,10R,13S,16S,22S).
Table 2.
1H NMR data (500 MHz) of teraspiridoles A–D (2–5) in CD3OD
| position | 2
|
3
|
4
|
5
|
|---|---|---|---|---|
| δH, mult, (J in Hz) | δH, mult, (J in Hz) | δH, mult, (J in Hz) | δH, mult, (J in Hz) | |
| 1 | 6.77 d (12.1) | 6.76 d (12.1) | 1.85 m; 1.70 m | 1.82 m; 1.70 m |
| 2 | 5.92 d (12.1) | 5.91 d (12.1) | 2.80 ddd (4.8, 13.2, 14.0) | 2.79 m |
| 2.54 ddd (4.2, 4.3, 14.0) | 2.54 ddd (3.9, 4.4, 14.7) | |||
| 5 | 2.36 dd (3.5, 13.3) | 2.33 dd (3.6, 13.3) | 2.23 dd (2.6, 12.7) | 2.21 dd (2.7, 13.0) |
| 6 | 1.75 m; 1.89 m | 1.75 m; 1.86 m | 1.85 m; 1.66 m | 1.85 m; 1.70 m |
| 7 | 4.60 dd (4.3, 11.2) | 4.55 dd (4.4, 11.4) | 4.60 dd (4.0,11.5) | 4.56 dd (3.9, 11.2) |
| 9 | 1.52 br d (11.2) | 1.50 br d (11.4) | 1.35 br d (10.0) | 1.34 m |
| 11 | 1.95 m; 1.82 m | 1.94 m; 1.75 m | 1.85 m; 1.66 m | 1.85 m; 1.70 m |
| 12 | 1.75 m; 2.04 br d (11.4) | 1.75 m; 2.04 m | 2.00 m; 1.66 m | 2.00 m; 1.70 m |
| 14 | 2.08 dd (6.6, 13.5) | 2.04 m | 2.00 m | 2.00 m |
| 15 | 2.99 dd (12.7, 13.5) | 2.80 dd (11.9, 13.6) | 2.99 dd (12.6, 13.1) | 2.80 dd (13.0, 13.0) |
| 1.18 dd (6.6, 12.7) | 1.19 m | 1.19 dd (6.5, 12.6) | 1.19 m | |
| 17 | 1.29 s | 1.33 s | 1.27 s | 1.31 s |
| 18 | 1.27 s | 1.26 s | 1.11 s | 1.10 s |
| 19 | 1.14 s | 1.12 s | 1.11 s | 1.10 s |
| 20 | 1.46 s | 1.44 s | 1.42 s | 1.41 s |
| 21 | 1.43 s | 1.41 s | 1.51 s | 1.50 s |
| 22 | 5.43 s | 5.49 s | 5.43 s | 5.49 s |
| 23 | 4.24 br q (6.8) | 4.24 q (6.8) | ||
| 26 | 7.43 br d (7.9) | 7.35 br d (7.9) | 7.44 d (7.8) | 7.36 br d (7.8) |
| 27 | 7.31 br dd (7.6, 7.9) | 7.31 br dd (7.5, 7.9) | 7.32 dd (7.6, 7.8) | 7.33 br dd (7.2, 7.8) |
| 28 | 7.17 br dd (7.6, 8.0) | 7.21 ddd (7.4, 7.5, 1.5) | 7.18 dd (7.5, 7.6) | 7.22 br dd (7.2, 7.6) |
| 29 | 7.41 br d (8.0) | 7.39 br d (7.4) | 7.39 d (7.5) | 7.38 br d (7.6) |
| 31 | 1.32 d (6.8) | 1.31 m; 1.17 m | 1.32 d (6.8) | 1.34 m; 1.19 m |
| 31a | 1.13 m; 0.87 m | 1.14 m; 0.88 m | ||
| 33 | 1.89 s | 1.87 s | 1.89 s | 1.87 s |
Two more structurally-related metabolites, teraspiridoles C and D (4 and 5, respectively),13 were also obtained from the A. terreus extract. Compounds 4 and 5 were determined to have molecular formulae consisting of C33H44N2O6 and C34H44N2O6, respectively, based on HRESIMS. Both compounds exhibited 13C NMR resonances similar to 2 and 3 (Table 1) with the exceptions being that in each instance, the C-1 and C-2 olefinic methines were replaced by methylenes. Further evidence for the increased saturation at these positions was afforded by 1H NMR, which revealed new proton resonances at δ1.70, 1.85, 2.54, and 2.80, as well as δ 1.70, 1.82, 2.54, and 2.79 for 4 and 5, respectively. Confirmation of the planar structures of 4 and 5 was provided by analysis of COSY and HMBC correlation data (Supporting Information, Figure S3) that demonstrated these compounds shared the same atom arrangements as their unsaturated analogs. Additionally, ROESY correlation data (Supporting Information, Figure S3) indicated that 4 and 5 possessed the same relative configurations as 2 and 3, respectively. Finally, quantum chemical ECD calculations (Supporting Information, Figure S4) enabled us to independently establish the absolute configurations of 4 (5R,7S,8R,9R,10R,13S,16S,22S,23S) and 5 (5R,7S,8R,9R,10R,13S,16S,22S).
Compound 2–5 were evaluated for their biological activity in a panel of assays (cancer cell cytotoxicity,14 antibiosis against pathogenic bacteria and fungi, 15 disruption of Candida biofilm formation,16 and inhibition of planarian regeneration and survival.17) Only compound 3 exhibited weak activity in the planaria assay (Supporting Information, Figure S5). At a concentration of 75 μM, approximately 80% of the planarian segments did not regenerate, but instead disintegrated within 48 h. At 50 and 25 μM, no degeneration of the planarian fragments occurred; however, the surviving body segments appeared to regenerate more slowly, with the planaria exhibiting sluggish swimming motions.
There are relatively few examples of the incorporation of 1 into natural products with 2–5 representing the first examples of this scaffold being linked to a terpenoid backbone. Although the compounds exhibited limited biological activities, we find their novel structural features highly valuable for adding a new element of chemical diversification to our pure natural product library.
Supplementary Material
Acknowledgments
Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health RO1GM092219, a Challenge Grant from the Office of the Vice President for Research, University of Oklahoma, and an award through the Shimadzu Equipment Grant Program.
Footnotes
The authors declare no competing financial interest.
Supporting Information Available NMR (1H and 13C NMR, HSQC, COSY, HMBC, and ROESY) and HRESIMS data for compounds 2–5. Fungal identification and associated data. This information is available free of charge via the Internet at http://pubs.acs.org.
References
- 1.Gao X, Chooi Y, Ames BD, Wang P, Walsh CT, Tang Y. J Am Chem Soc. 2011;133:2729–2741. doi: 10.1021/ja1101085. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Takahashi C, Matsushita T, Doi M, Minoura K, Shingu T, Kumeda Y, Numata A. J Chem Soc Perkin Trans 1. 1995:2345–2353. [Google Scholar]
- 3.Clardy J, Springer JB, Buchi G, Matsuo K, Wightman R. J Am Chem Soc. 1975;97:663–665. doi: 10.1021/ja00836a045. [DOI] [PubMed] [Google Scholar]
- 4.(a) Zhuang Y, Teng X, Wang Y, Liu P, Li G, Zhu W. Org Lett. 2011;13:1130–1133. doi: 10.1021/ol103164n. [DOI] [PubMed] [Google Scholar]; (b) Larsen TO, Peterssen BO, Duus JØ, Sørensen D, Frisvad JC, Hansen ME. J Nat Prod. 2005;68:871–874. doi: 10.1021/np040248s. [DOI] [PubMed] [Google Scholar]; (c) Zhou Y, Debbab A, Mándi A, Wray V, Schulz B, Müller WEG, Kassack M, Lin W, Kurtán T, Proksch P, Aly AH. Eur J Org Chem. 2013:894–906. [Google Scholar]; (d) Barros FAP, Rodrigues-Filho E. Biochem Syst Ecol. 2005;33:257–268. [Google Scholar]
- 5.Yeung BKS, Nakao Y, Kinnel RB, Carney JR, Yoshida WY, Shcheuer PJ, Kelly-Borges M. J Org Chem. 1996;61:7168–7173. doi: 10.1021/jo960725e. [DOI] [PubMed] [Google Scholar]
- 6.Jiao RH, Xu S, Liu JY, Ge HM, Ding H, Xu C, Zhu HL, Tan RX. Org Lett. 2006;8:5709–5712. doi: 10.1021/ol062257t. [DOI] [PubMed] [Google Scholar]
- 7.Khaldi N, Collemare J, Lebrun M, Wolfe KH. Genome Biology. 2008;9:R18. doi: 10.1186/gb-2008-9-1-r18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Du L, King JB, Morrow BH, Shen JK, Miller AN, Cichewicz RH. J Nat Prod. 2012;75:1819–1823. doi: 10.1021/np300473h. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Teraspiridole A (2): pale yellow solid; [α]24 D +68.0 (c 0.2, CHCl3); UV (MeOH) λmax (log ε) 210 (4.38), 252 (3.99); IR (film) νmax 3340, 2984, 2933, 1706, 1483, 1387, 1293, 1242, 1183, 1155, 1115, 1078, 1015, 980, 755 cm−1; 1H and 13C NMR data, see Tables 1 and 2; HRESIMS m/z 563.3117, [M + H]+ (calcd for C33H43N2O6, 563.3121).
- 10.Liu J-Q, Wang C-F, Li Y, Chen J-C, Zhou L, Qiu M-H. Phytochemistry. 2012;76:141–149. doi: 10.1016/j.phytochem.2012.01.002. [DOI] [PubMed] [Google Scholar]
- 11.Marfey P. Carlsberg Res Commun. 1984;49:591–596. [Google Scholar]
- 12.Teraspiridole B (3): pale yellow solid; [α]24 D +28.0 (c 0.2, CHCl3); UV (MeOH) λmax (log ε) 208 (4.54), 252 (3.92); IR (film) νmax 3327, 2985, 2944, 1713, 1478, 1386, 1292, 1243, 1186, 1155, 1115, 1026, 1016, 981, 756 cm−1; 1H and 13C NMR data, see Tables 1 and 2; HRESIMS m/z 575.3116, [M + H]+ (calcd for C34H43N2O6, 575.3121).
- 13.Teraspiridole C (4): pale yellow solid; [α]24 D +62.8 (c 0.175, CHCl3); UV (MeOH) λmax (log ε) 210 (4.34), 252 (4.01); IR (film) νmax 3346, 2978, 2929, 1710, 1604, 1482, 1391, 1293, 1244, 1183, 1145, 1064, 1014, 979, 756 cm−1; 1H and 13C NMR data, see Tables 1 and 2; HRESIMS m/z 565.3276, [M + H]+ (calcd for C33H45N2O6, 565.3278). Teraspiridole D (5): pale yellow solid; [α]24 D +14.4 (c 0.125, CHCl3); UV (MeOH) λmax (log ε) 210 (4.34), 252 (3.97); IR (film) νmax 3345, 2982, 2926, 1722, 1605, 1477, 1373, 1305, 1293, 1245, 1155, 1145, 1065, 979, 756 cm−1; 1H and 13C NMR data, see Tables 1 and 2; HRESIMS m/z 577.3272, [M + H]+ (calcd for C34H45N2O6, 577.3278).
- 14.Joyner PM, Waters AL, Williams RB, Powell DR, Janakiram NB, Rao CV, Cichewicz RH. J Nat Prod. 2011;74:857–861. doi: 10.1021/np100775a. [DOI] [PubMed] [Google Scholar]
- 15.(a) Wang X, Filho JGS, Hoover AR, King JB, Ellis TK, Powell DR, Cichewicz RH. J Nat Prod. 2010;73:942–948. doi: 10.1021/np100142h. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Henrikson JC, Ellis TK, King JB, Cichewicz RH. J Nat Prod. 2011;74:1959–1964. doi: 10.1021/np200454z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Wang X, You J, King JB, Powell DR, Cichewicz RH. J Nat Prod. 2012;75:707–715. doi: 10.1021/np2009994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Chan JD, Marchant JS. J Vis Exp. 2011;54:e3058. doi: 10.3791/3058. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.



